Introduction
Coronary artery disease (CAD) has been increasing in recent years because of the aging of the population and the westernization of lifestyles. 1, 2 Treatment and prevention of acute coronary syndrome (ACS) is imperative because of the lethality of the disease. The incidence of ACS will inevitably increase in the near future owing to the rapidly increasing age of the population. Therefore, more attention should be paid to the management of patients with ACS. The present study focused on the causes of death in patients with ACS.
Methods
This was a single-center retrospective observational study performed at Juntendo University Hospital located in the center of Tokyo. We retrospectively investigated the deaths of patients with a first diagnosis of ACS who were admitted to our hospital from January 1997 to December 2011 and underwent emergency percutaneous coronary intervention (PCI), as far as we could identify their long-term prognosis.
We assessed the cause of death in the both short-term (within three months after ACS) and long-term (over three months after ACS) in addition to baseline clinical characteristics at admission. The cause of death was classified as fatal myocardial infarction (MI), fatal stroke, other cardiovascular death [heart failure (HF)
and others], non-cardiovascular death (pneumonia, other infection, cancer, senility, and others), or unknown. The cause of death was assessed from the medical records. This study was approved by the Institutional Ethics Committee of the hospital.
Results
We identified 221 patients who had died. Table 1 shows the baseline clinical characteristics at admission. 
Discussion
In the present study, we showed that the major causes of death in patients with ACS were fatal MI in the short-term follow up. In the long-term follow up, noncardiovascular death was the major cause of death. The major preventable causes of death were pneumonia and HF. This result may also be applicable to the Japanese general population.
The incidence of ACS in Japan has been increasing owing to the westernization of lifestyles and the aging population. The MIYAGI-AMI Registry Study revealed that the overall age-adjusted incidence of acute who have a medical history of stroke, because ACE-I are essential to improve the prognosis of heart failure and to help prevent aspiration pneumonia by increasing concentrations of bradykinin. [3] [4] [5] Pneumococcus is a major pathogenic bacterium that causes communityacquired pneumonia, and the pneumococcal vaccine is recommended for elderly patients. Several previous studies have shown that the influenza vaccine has a preventive effect on cardiovascular events. [6] [7] [8] [9] We investigated deaths by HF in the long-term by classifying the patients into a very elderly patient group aged ²75 years and a group aged <75 years, though the results of the investigation were not described in the Results section in the main text. Of 171 deaths in the long-term, 76 deaths occurred in the very elderly patient group, among which 12 deaths were caused by HF (12/76, 15.8%), whereas 95 deaths occurred in the younger patient group, among which 7 deaths were caused by HF (7/95, 7.4%). This indicated a higher incidence of death by HF in the very elderly group. In very elderly patients, standardized treatments for HF are not always pursued because of their low tolerability. 10 For example, beta-blockers are not administered in cases where bradycardia may be induced, or ACE-I/ARB are not administered if there is a possibility of hyperkalemia with chronic kidney disease.
There are two limitations to the present study. First, it was a single-center study and did not receive an external validity evaluation. Second, the duration of the study was >10 years (1997-2011), and medical advancements during this long period might have affected the results of the study. Therefore, multicentered prospective studies, focusing on cause of death in patients with ACS, are required to confirm the results of the present study.
Conclusion
We should recognize that the major causes of death in patients with ACS are fatal MI in the short-term outcome. Considering long-term outcomes, pneumonia and HF were an important preventable cause of death.
We should pay attention to the management of these diseases in patients with ACS.
